# ACTIV-6: COVID-19 Study of Repurposed Medications

> **NCT04885530** · PHASE3 · COMPLETED · sponsor: **Susanna Naggie, MD** · enrollment: 10956 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin
- **DRUG:** Fluvoxamine
- **DRUG:** Fluticasone
- **OTHER:** Placebo
- **DRUG:** Montelukast
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04885530
- **Lead sponsor:** Susanna Naggie, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-08
- **Primary completion:** 2024-04-29
- **Final completion:** 2024-04-29
- **Target enrollment:** 10956 (ACTUAL)
- **Last updated:** 2025-11-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04885530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04885530, "ACTIV-6: COVID-19 Study of Repurposed Medications". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04885530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*